363 related articles for article (PubMed ID: 27847554)
1. Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad.
Sparaneo A; Fabrizio FP; Muscarella LA
Oxid Med Cell Longev; 2016; 2016():7316492. PubMed ID: 27847554
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between Nrf2 and Notch signaling.
Wakabayashi N; Chartoumpekis DV; Kensler TW
Free Radic Biol Med; 2015 Nov; 88(Pt B):158-167. PubMed ID: 26003520
[TBL] [Abstract][Full Text] [Related]
3. Suppression of radiation-induced migration of non-small cell lung cancer through inhibition of Nrf2-Notch Axis.
Zhao Q; Mao A; Guo R; Zhang L; Yan J; Sun C; Tang J; Ye Y; Zhang Y; Zhang H
Oncotarget; 2017 May; 8(22):36603-36613. PubMed ID: 28402268
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 regulates cellular behaviors and Notch signaling in oral squamous cell carcinoma cells.
Fan H; Paiboonrungruan C; Zhang X; Prigge JR; Schmidt EE; Sun Z; Chen X
Biochem Biophys Res Commun; 2017 Nov; 493(1):833-839. PubMed ID: 28821430
[TBL] [Abstract][Full Text] [Related]
6. Role of NRF2 in Lung Cancer.
Sánchez-Ortega M; Carrera AC; Garrido A
Cells; 2021 Jul; 10(8):. PubMed ID: 34440648
[TBL] [Abstract][Full Text] [Related]
7. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1.
Na HK; Surh YJ
Free Radic Biol Med; 2014 Feb; 67():353-65. PubMed ID: 24200599
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Nrf2 promotes radiation-induced apoptosis through Nrf2 mediated Notch signaling in non-small cell lung cancer cells.
Zhao Q; Mao A; Yan J; Sun C; Di C; Zhou X; Li H; Guo R; Zhang H
Int J Oncol; 2016 Feb; 48(2):765-73. PubMed ID: 26691854
[TBL] [Abstract][Full Text] [Related]
10. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
[TBL] [Abstract][Full Text] [Related]
11. Notch-Nrf2 axis: regulation of Nrf2 gene expression and cytoprotection by notch signaling.
Wakabayashi N; Skoko JJ; Chartoumpekis DV; Kimura S; Slocum SL; Noda K; Palliyaguru DL; Fujimuro M; Boley PA; Tanaka Y; Shigemura N; Biswal S; Yamamoto M; Kensler TW
Mol Cell Biol; 2014 Feb; 34(4):653-63. PubMed ID: 24298019
[TBL] [Abstract][Full Text] [Related]
12. Interplay of MKP-1 and Nrf2 drives tumor growth and drug resistance in non-small cell lung cancer.
Wang H; Liu K; Chi Z; Zhou X; Ren G; Zhou R; Li Y; Tang X; Wang XJ
Aging (Albany NY); 2019 Dec; 11(23):11329-11346. PubMed ID: 31811110
[TBL] [Abstract][Full Text] [Related]
13. Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice.
Chartoumpekis DV; Yagishita Y; Fazzari M; Palliyaguru DL; Rao UN; Zaravinos A; Khoo NK; Schopfer FJ; Weiss KR; Michalopoulos GK; Sipula I; O'Doherty RM; Kensler TW; Wakabayashi N
JCI Insight; 2018 Mar; 3(5):. PubMed ID: 29515034
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
[TBL] [Abstract][Full Text] [Related]
15. Evidence of Notch-Hesr-Nrf2 Axis in Muscle Stem Cells, but Absence of Nrf2 Has No Effect on Their Quiescent and Undifferentiated State.
Yamaguchi M; Murakami S; Yoneda T; Nakamura M; Zhang L; Uezumi A; Fukuda S; Kokubo H; Tsujikawa K; Fukada S
PLoS One; 2015; 10(9):e0138517. PubMed ID: 26418810
[TBL] [Abstract][Full Text] [Related]
16. Continuous activation of Nrf2 and its target antioxidant enzymes leads to arsenite-induced malignant transformation of human bronchial epithelial cells.
Yang X; Wang D; Ma Y; Xu X; Zhu Z; Wang X; Deng H; Li C; Chen M; Tong J; Yamanaka K; An Y
Toxicol Appl Pharmacol; 2015 Dec; 289(2):231-9. PubMed ID: 26420645
[TBL] [Abstract][Full Text] [Related]
17. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
Chian S; Thapa R; Chi Z; Wang XJ; Tang X
Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
[TBL] [Abstract][Full Text] [Related]
19. Review of molecular mechanisms involved in the activation of the Nrf2-ARE signaling pathway by chemopreventive agents.
Giudice A; Arra C; Turco MC
Methods Mol Biol; 2010; 647():37-74. PubMed ID: 20694660
[TBL] [Abstract][Full Text] [Related]
20. NRF2 Regulates HER2 and HER3 Signaling Pathway to Modulate Sensitivity to Targeted Immunotherapies.
Khalil HS; Langdon SP; Kankia IH; Bown J; Deeni YY
Oxid Med Cell Longev; 2016; 2016():4148791. PubMed ID: 26770651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]